Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...
One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...
"This action and the agency’s designations to expedite the drug’s development and review underscore FDA’s commitment to ...
AI is reshaping drug discovery and development by streamlining workflows, predicting molecular interactions and optimizing clinical trials, thereby reducing reliance on traditional, slower methods.
Understanding the mechanisms of resistance to cancer treatments is necessary to find effective therapies at different stages of the disease. Scientists at UT Southwestern Medical Center studied the ...
This summary is generated by Google AI, and its accuracy and relevance may vary. Please consult the detailed list of results for greater precision.
Examining risk reduction linked to already prescribed medications can complement the traditional drug discovery approach. For example, some diabetes drugs, as well as benzodiazepines, have been found ...
This could lead to faster drug development, cheaper costs, and new cures. Yet discovering the drugs is merely one step in the process. it’s only when big pharma decides they’re worth ...
In 2019, Stanford University professor Irv Weissman and a colleague published a paper that represented a new way to target some aggressive cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback